• Information

    Expanding in HMOs

    30 November 2018

    At HiE 2018 in Frankfurt, NutritionInsight spoke with Christian Metzmacher of Jennewein Biotechnologie about the company's most recent work with human milk oligosaccharides (HMOs). “We invented a specific fermentation process to produce these HMOs. As it turned out, there's a huge demand so we increased our production capacities by about 300 percent in the past 18 months,” he says, adding that this demand is driven by a desire to bridge the gap between breastmilk and infant formula.